Downloaded from molecularcasestudies.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press Metastatic PNET molecular characteristics Manuscript Research Report Molecular characterisation of metastatic pancreatic neuroendocrine tumours (PNETs) using whole genome and transcriptome sequencing Hui-li Wong1,2†, Kevin C. Yang3,4†, Yaoqing Shen4†, Eric Y. Zhao4, Jonathan M. Loree1, Hagen F. Kennecke1, Steve E. Kalloger2,5, Joanna M. Karasinska2, Howard J. Lim1, Andrew J. Mungall4, Xiaolan Feng6, Janine M. Davies1, Kasmintan Schrader7, Chen Zhou4, Aly Karsan4, Steven J.M. Jones4, Janessa Laskin1, Marco A. Marra4,7, David F. Schaeffer2,5‡, Sharon M. Gorski3,4‡, Daniel J. Renouf1,2‡ 1Division of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada 2Pancreas Centre BC, Vancouver, British Columbia, Canada 3Department of Molecular Biology and Biochemistry, Simon Fraser University, Vancouver, British Columbia, Canada 4Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada 5Division of Anatomical Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada 6Vancouver Island Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada 7Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada †These authors contributed equally to this work ‡These authors jointly supervised this work Corresponding author: Daniel J. Renouf Email:
[email protected] Running title: Metastatic